Early Goal Directed Therapy in Sepsis by Emergency Medical Services

April 13, 2017 updated by: Michael Filbin, MD, Massachusetts General Hospital

Early Goal Directed Therapy in Sepsis by EMS

The goal is to evaluate the best way for paramedics and hospitals to work together to treat septic patients as quickly as possible.

The investigators think that the best thing to do for septic patients is to identify and treat them as early as possible. This research will test this. The investigators think that if paramedics identify septic patients and begin treatment with fluids in the ambulance, then the patient will do better in the long run. The paramedic will also tell the hospital that a septic patient will be there soon. The caregivers can prepare and be ready to provide care as soon as the patient arrives. With this research, the investigators would like to see if these steps help patient outcomes.

Study Overview

Status

Withdrawn

Conditions

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Cambridge, Massachusetts, United States, 02138
        • Mount Auburn Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Older than 17 years of age
  • Suspected to having an infection
  • Meets 2 of 3 systemic inflammatory response criteria: heart rate > 90 beats per minute, respiratory rate >20 breaths per minute, temperature >38°C or <36°C

Exclusion Criteria:

  • Transfer from another hospital
  • Patients, coming from a rehabilitation/nursing facility where antibiotics were given prior to transfer
  • Pregnant patients
  • Prisoners.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prehospital-directed therapy arm
Patients who are hypotensive or whose lactate is ≥ 2.5, prehospital providers will provide a notification to the receiving hospital (Hospital Notification), establish an IV, and provide 1 liter normal saline (NS) bolus of IV fluids. An additional 1 liter normal saline bolus will be given for systolic blood pressure less than 100. Patients who have a history of end-stage renal disease or congestive heart failure would receive only 20 milliliters/kilogram of fluid. If the patient remains hypotensive, Emergency Medical Services will continue providing fluids as is standard of care.
Normal Saline 0.9%
Prehospital providers will notify the receiving hospital over the radio or telephone that they are transporting a patient who meets Sepsis Criteria
Experimental: Control Arm
Prehospital providers will obtain a point of care lactate, establish an IV, and provide IV fluids as judged necessary.
Normal Saline 0.9%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time to antibiotics
Time Frame: During the Emergency Department stay (expected to be 5 hours)
During the Emergency Department stay (expected to be 5 hours)

Secondary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Participants will be followed for the duration of hospital stay, an expected average of 1 week
Need for pressors in the Emergency Department
Time Frame: During the Emergency Department stay (expected to be 5 hours)
During the Emergency Department stay (expected to be 5 hours)
Admitted to the Intensive Care Unit from the Emergency Department
Time Frame: During the Emergency Department stay (expected to be 5 hours)
During the Emergency Department stay (expected to be 5 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Filbin, MD, Massachusetts General Hospital
  • Principal Investigator: William Porcaro, MD, MPH, Mount Auburn Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Anticipated)

May 1, 2017

Study Completion (Anticipated)

May 1, 2017

Study Registration Dates

First Submitted

June 9, 2014

First Submitted That Met QC Criteria

October 13, 2014

First Posted (Estimate)

October 17, 2014

Study Record Updates

Last Update Posted (Actual)

April 17, 2017

Last Update Submitted That Met QC Criteria

April 13, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on IV fluids

3
Subscribe